4.6 Article

Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey

期刊

SURGERY
卷 172, 期 6, 页码 S29-S37

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2022.06.036

关键词

-

类别

资金

  1. Diagnostic Green
  2. Intuitive
  3. Medtronic
  4. Olympus
  5. Karl Storz
  6. Stryker
  7. Arthrex
  8. Richard Wolf

向作者/读者索取更多资源

This study aimed to identify areas of consensus among international experts on the use of fluorescence imaging with indocyanine green for mapping sentinel lymph nodes during gastric cancer surgery. Consensus was reached on various aspects, including the injection location and dosage of the fluorescent agent, as well as the advantages and limitations of the technique. However, further research is needed before this technology can be widely used in clinical practice.
Background: Understanding the extent of tumor spread to local lymph nodes is critical to managing early-stage gastric cancer. Recently, fluorescence imaging with indocyanine green has been used to identify and characterize sentinel lymph nodes during gastric cancer surgery, but no published guidelines exist. We sought to identify areas of consensus among international experts in the use of fluorescence imaging with indocyanine green for mapping sentinel lymph nodes during gastric-cancer surgery. Methods: In this 2-round, online Delphi survey, 27 international experts voted on 79 statements pertaining to patient preparation and contraindications to fluorescence imaging with indocyanine green during gastric cancer surgery; indications; technical aspects; advantages/disadvantages and limitations; and training and research. Methodological steps were adopted during survey design to minimize bias. Results: Consensus was reached on 61 of 79 statements, including giving single injections of indocyanine green into each of the 4 quadrants peritumorally, administering indocyanine green on the same day as surgery, injecting a total of 1 to 5 mL of 5 mg/mL indocyanine green, injecting endoscopically into submucosa, and repeating indocyanine green injections a second time if sentinel lymph node visualization remains inadequate. Consensus also was reached that fluorescence imaging with indocyanine green is an acceptable single-agent modality for sentinel lymph node identification and that the sentinel lymph node basin method is preferred. However, sentinel lymph node dissection should be limited to T1 gastric cancer and tumors <= 4 cm in diameter, and further research is necessary to optimize the technique and render fluorescence-guided sentinel lymph nodes dissection acceptable for routine clinical use. Conclusion: Although considerable consensus was achieved, further research is necessary before this technology should be used in routine practice. (c) 2022 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据